Silence Therapeutics plc (SLN) has a market capitalization of $343.86M and trades at $7.28. The 52-week range is 1.97-7.91.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.9, Earnings Per Share (EPS) of $-1.89, annual revenue of $559K.
The stock has a beta of 1.33, operates in the Healthcare sector.
